Reactogenicity to COVID-19 vaccination in the United States of America

PURPOSE: In the United States, Pfizer-BioNTech, Moderna, and Janssen’s coronavirus disease 2019 (COVID-19) vaccines have been granted Emergency Use Authorization (EUA) with the Pfizer-BioNTech vaccine presently approved by the US Food and Drug Administration. The purpose of this study is to analyze...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanyaolu, Adekunle, Marinkovic, Aleksandra, Prakash, Stephanie, Desai, Priyank, Haider, Nafees, Abbasi, Abu Fahad, Mehraban, Nasima, Jain, Isha, Ekeh, Amarachi, Shazley, Omar, Okorie, Chuku, Orish, Verner N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2022
Materias:
Covid-19 Special
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844673/
https://www.ncbi.nlm.nih.gov/pubmed/35223671
http://dx.doi.org/10.7774/cevr.2022.11.1.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844673/
https://www.ncbi.nlm.nih.gov/pubmed/35223671
http://dx.doi.org/10.7774/cevr.2022.11.1.104

Ejemplares similares